QCI Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
QCI Asset Management's XBI Position: Q2 2020 in Review
QCI Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2020, closing a stake of 100 shares — an estimated $8K sold.
QCI Asset Management first reported a position in XBI in Q1 2020 and held it in 1 quarter. The position peaked at $8K in Q1 2020. 525 funds tracked by Wall St. Rank hold XBI as of Q2 2020.
- QCI Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2020 after selling out during the quarter.
- QCI Asset Management sold 100 State Street SPDR S&P Biotech ETF shares in Q2 2020, an estimated $8K.
- QCI Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and held it in 1 quarter.
- QCI Asset Management's State Street SPDR S&P Biotech ETF position peaked at $8K in Q1 2020.
- 525 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2020.
Based on QCI Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.